These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2624186)

  • 1. Hypoxanthine accumulation and dopamine depletion in Lesch-Nyhan disease.
    Palmour RM; Heshka TW; Ervin FR
    Adv Exp Med Biol; 1989; 253A():165-72. PubMed ID: 2624186
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesch-Nyhan syndrome.
    Norstrand IF
    N Engl J Med; 1982 Jun; 306(22):1368. PubMed ID: 7070471
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxanthine salvage in man: its importance in urate overproduction in the Lesch-Nyhan syndrome.
    Edwards NL; Recker DP; Fox IH
    Adv Exp Med Biol; 1980; 122A():301-6. PubMed ID: 7424648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease.
    Torres RJ; Prior C; Garcia MG; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):507-516. PubMed ID: 27906640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine metabolism in permanent lymphocyte lines and in erythrocytes of patients with the Lesch-Nyhan syndrome.
    Reem GH
    Adv Exp Med Biol; 1977; 76A():384-90. PubMed ID: 855718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Langlais PJ; Friedmann T
    J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine.
    Criswell H; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):493-500. PubMed ID: 3126293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of striatal dopaminergic function by local injection of 5'-N-ethylcarboxamide adenosine.
    Green RD; Proudfit HK; Yeung SM
    Science; 1982 Oct; 218(4567):58-61. PubMed ID: 7123218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of purine utilization in cultured fibroblasts, amniocytes and chorionic villi: an attempt towards understanding clinical variability in Lesch-Nyhan syndrome.
    Singh S; Willers I; Held K; Godde HW
    Adv Exp Med Biol; 1986; 195 Pt A():143-51. PubMed ID: 3728147
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome.
    Kish SJ; Fox IH; Kapur BM; Lloyd K; Hornykiewicz O
    Brain Res; 1985 Jun; 336(1):117-23. PubMed ID: 2988699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.
    Lloyd KG; Hornykiewicz O; Davidson L; Shannak K; Farley I; Goldstein M; Shibuya M; Kelley WN; Fox IH
    N Engl J Med; 1981 Nov; 305(19):1106-11. PubMed ID: 6117011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients.
    Torres RJ; DeAntonio I; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1193-6. PubMed ID: 15571229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine function in Lesch-Nyhan disease.
    Nyhan WL
    Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):409-11. PubMed ID: 10852837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    J Inherit Metab Dis; 2012 Nov; 35(6):1129-35. PubMed ID: 22403020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
    Lowy BA; Williams MK
    Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.
    Fairbanks LD; Jacomelli G; Micheli V; Slade T; Simmonds HA
    Biochem J; 2002 Aug; 366(Pt 1):265-72. PubMed ID: 11996669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesch-Nyhan syndrome: incorporation of hypoxanthine in stimulated lymphocytes.
    de Bruyn CH; Oei TL
    Exp Cell Res; 1973 Jun; 79(2):450-2. PubMed ID: 4798705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.